COL8A1 Promotes Tumor in Pancreatic Ductal Adenocarcinoma
Yan et al. identified COL8A1 as a potential biomarker of poor chemotherapy response and survival in PDAC. TissueFAXS and StrataQuest enabled imaging and segmentation of tumor structures.
Customer Publication

COL8A1 Promotes Tumor in Pancreatic Ductal Adenocarcinoma
11 Nov, 2022